Investor Ideas #Potcasts,
#Cannabis News and #Stocks on the Move: Interview with CEO of Global Cannabis
Applications Corp. (CSE: $APP.C) (OTC: $FUAPF) @CitizenGreenWld
Delta, Kelowna, BC, April 29, 2021 (Investorideas.com Newswire) www.Investorideas.com,
a global news source covering leading sectors including marijuana and hemp
stocks and its potcast site, www.potcasts.ca release
today’s special edition of cannabis news
and stocks to watch plus insight from thought leaders and experts, featuring an
exclusive interview with Brad Moore, CEO of Global Cannabis Applications Corp. (CSE:
APP)
(OTC:
FUAPF).
Global Cannabis Applications Corp, (“GCAC”)
is a global leader in designing, developing, SaaS licensing and acquiring
innovative blockchain data technologies for the medical cannabis industry.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/042621-Cannabis-GCAC.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/04291APP-FUAPF.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Brad
Moore, CEO of Global Cannabis
Applications Corp. (CSE:
APP)
(OTC:
FUAPF) discusses the
recent launch
of the GCAC token on Uniswap as part of a
digital marketing campaign aimed at the one million decentralized finance user
community ‘DeFi,’ as well their
definitive three-year software licensing agreement with Herb Industries Ltd., a Malta-based
medical cannabis cultivator.
Commenting
on the GCAC Uniswap token Moore said, “A large portion of our consumer base,
and when I say our consumer base I’m talking about the CBD, recreational
marijuana and medical cannabis consumer base, are people between ages 30 to 45,
millennials starting families and also the people willing to use cannabis products,
and cannabis as a whole, without a lot of the preconceptions and stereotypes.
They are more open to ideas and understanding, and because they’re more open,
they have also embraced cryptocurrencies. We understand that this is a target
demographic. The reason we did the GCAC token marketing program part of the
opportunity, is because our whole business is based on the Ethereum Blockchain. Actually we were the
first cannabis company globally to announce our Ethereum 2.0 rollup-centric roadmap. So, it
only makes sense that we start marketing to like-minded people.”
Moore
continued, “So, we entered into a two-year marketing contract with Abbey Technology
in Switzerland and they designed and published the GCAC token on Ethereum, that
token went out and now 400+ people who didn’t know about what GCAC did with
Efixii and our QR Code system now did, and that’s important. At the same time,
what we did was purchase a bunch of the GCAC tokens on the open market and now
we’ve got a nice Ethereum cryptocurrency-based asset for our balance sheet. So,
for all our shareholders it was a pretty good move. If it’s good enough for
Elon Musk to put Bitcoin on Tesla, it’s good enough for Brad Moore out of
Vancouver. So, for at least the next two years, we’ve committed to put 1% of
our top line revenue into this Abbey Technology marketing program to create
awareness and to keep it going. The best way to keep awareness going is to buyback
GCAC tokens with this 1% after each and every financial quarter.”
As reported last month on Global
News, “Tesla (NASDAQ:TSLA) customers
could now buy its electric vehicles with bitcoin marking a significant step
forward for the cryptocurrency’s use in commerce.”
“You can now buy a Tesla with
bitcoin,” Musk said on Twitter, adding that the option would be available
outside the United States later this year.
For GCAC, their multi-year marketing
campaign aims to raise awareness of its Citizen Green products and it’s Efixii
‘QR codes’ by launching a Uniswap token on the Ethereum blockchain with the
Company’s name, logo and website visible to all of the Uniswap community.
GCAC’s Uniswap-inclusion marketing
initiative is to commit to a marketing-spend of 1% of its quarterly sales
revenue buying GCAC tokens on Uniswap every 3 months. Each Uniswap token-buy
should lead to greater awareness of the Company’s products and drive potential
new cannabis consumers to look for Efixii ‘QR codes’ on the products they are
purchasing on-line.
Moore went on to discuss how their
recent deal with Herb Industries ties in with their recent marketing campaign.
“When you take a look at Herb Industries, by far our biggest deal, they’re projected
to do 44 million grams in 2022, and you look at my goal for 98 million grams by
next year, that’s pretty much 50% of that target in that one deal alone. With
the revenues that we bring in, up to a potential $160,000 buying GCAC tokens on
the Uniswap market, so it’s very timely that the deal closed, and we planned to
do the token marketing around 4/20, because it shows we are committed to
marketing to this demographic. We want consumers to know that, with Efixii,
there’s a better and safer way to consume cannabis products.”
GCAC is licensing its Citizen Green
Efixii platform as part of Herb’s ‘technology farm’ for use in its cannabis
compliance and consumer transparency platform. Herb’s advanced-growth-method
handles all production lifecycles from genetics, cannabis nursery, onsite ISO
laboratory and extraction. Licensed by the Maltese government, Herb’s 12,000
SQM facility’s manufacturing lines will export to other EU members’ markets for
pharmaceuticals, solids, semi solids, liquids, flowers, cosmetics and edibles.
GCAC’s Software-as-a-Service license
model meets the needs of cultivators as they scale. Cannabis lifecycle steps
are represented by GCAC’s Efixii QR-code which can be scanned by customs
officials, regulators, medical professionals and consumers alike to ensure that
products are what they claim to be. GCAC charges a one-time configuration fee
of $12,500 (USD), $50 per registered employee per month for KYC/AML, an export
fee of $75 per cannabis batch and a consumer Efficacy-QR-code fee of $75 per
retail product; in total, these fees generate CDN$.20/gram with a further
potential yield of CDN$.18/gram in future data sales.
“44M grams in 2022 and 66M grams
every year thereafter is an absolutely massive revenue opportunity for us on a
per gram basis” states GCAC’s CEO, Brad Moore. “And just as important, is
knowing that tens of thousands of EU consumers trust Efixii’s QR-codes to give
them, and their families comfort knowing what they are ingesting is the safest
and best product for them, thereby cementing our efficacy commitment of better
outcomes for medical cannabis patients and recreational consumers.”
The European cannabis market is the
largest in the world, with a forecast CAGR of 67.4% set to value the market at
€3.2 billion by 2025. The growth of the EU market since 2019 is attributed to
consumer demand for CBD and the upgrading of regulations for medical cannabis.
Key to meeting those regulations and building consumer confidence will be
Herb’s use of the Efixii compliance platform. Efixii enables growers’ staff to
record all events for cannabis cultivations, including mother plant, laboratory
tests, shipment, processing and customs.
Moore
went on to discuss in more detail his personal story dealing with cancer and
the difficulty navigating the current medical cannabis landscape, the long term
potential of the Efixii QR Code system for the medical cannabis industry as
well as how blockchain could influence the future of cannabis regulations.
“I
really want people to understand this. In the same way that cryptocurrency has
upended banking, blockchain, in our industry, can help create the framework for
meaningful regulations and better cannabis products.”
About Global
Cannabis Applications Corp. “GCAC”
GCAC
is a global leader in designing, developing, SaaS licensing and acquiring
innovative data technologies for the medical cannabis industry. The Citizen
Green and Efixii platforms are the world's first end-to-end - from patient to
regulator - medical cannabis data solutions. They use six core technologies:
mobile applications, artificial intelligence, RegTech, smart databases,
Ethereum blockchain and GCAC smart rewards. These technologies transparently
disclose cannabis chain-of-custody events, thereby enabling patients to provide
crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis
industry experts, GCAC is focused on generating revenue from SaaS licensing its
technology and acquiring high quality cannabis datasets that improve patient
outcomes and to become the world’s largest cannabis efficacy data provider.
For
more Company information, please visit www.cannappscorp.com, or review its
profiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google Play
Music and most audio platforms available.
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure:
Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. This podcast distribution featuring Global Cannabis Applications Corp.was
a paid for service on Investorideas.com ( 2000) More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news content services including podcasts
and tag articles on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
No comments:
Post a Comment